about
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003Vaccination for preventing postherpetic neuralgiaHerpes viruses hedge their betsSevere complications associated with varicella: Province of Quebec, April 1994 to March 1996Herpes zoster and postherpetic neuralgia surveillance using structured electronic data.Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.ORF7 of varicella-zoster virus is a neurotropic factor.Varicella vaccination--a critical review of the evidence.Presentation and management of herpes zoster (shingles) in the geriatric population.Successes and challenges in varicella vaccineVaricella-zoster virus: atypical presentations and unusual complications.The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latencyVaricella-zoster virus pneumonia in an adult population: has mortality decreased?Necrotizing fasciitis secondary to chickenpox infection in children.Complications of varicella in a defined central European population.Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based studyGenotypic analysis of varicella-zoster virus and its seroprevalence in Finland.Severe complications of chickenpox in hospitalised children in the UK and Ireland.Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen testVaricella susceptibility in a Canadian population.Viruses in periodontal disease - a review.Is Europe ready to embrace a policy of universal varicella vaccination?A meta-analysis of stroke risk following herpes zoster infectionVaricella vaccination in Australia.A case of fulminant varicella infection with purpura fulminans, hepatitis, and rhabdomyolysisNeuroepidemiology and the epidemiology of viral infections of the nervous systemNonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease.Seroepidemiology of varicella-zoster virus in Korea.Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.Cost-effectiveness of varicella vaccination programs: an update of the literature.Varicella Infection Complicated by Group A Beta-Hemolytic Streptococcal Retropharyngeal Abscess.Varicella pneumonia in adults: 13 years' experience with review of literature.Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.Varicella zoster virus vaccines: potential complications and possible improvements.Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.Two cases of herpes zoster appearing after botulinum toxin type a injections.Risk Factors for Varicella Susceptibility Among Refugees to Toronto, Canada.Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.
P2860
Q21257242-5B47410E-F15C-46DE-9127-A7248CD53190Q24235822-5E64FD88-137C-4E70-B448-6FB50E827F76Q24538630-088F1402-5541-43B5-BA52-D65E567E886CQ33378054-74148229-48CA-4BFA-BBE6-A0750A3D8BB7Q34047979-2FA60B81-BFEC-43A9-A4FB-DBEB79BDAD1DQ34265188-47E9C6AA-2B6A-4DEE-A556-168652F683BEQ34295291-3090DFE1-68F6-435E-B16A-2C6A86D210C4Q34315355-927F59D6-E903-445A-9BB5-6EA3CC36D124Q34352218-26DB84EC-037A-4EC2-B27D-944D10068CF8Q34416710-D1046678-E1E6-4697-8E59-7AC072C1F76BQ34527694-3E213203-FB1A-4042-8097-1DF58C311359Q34585593-F3316449-074A-4AC0-9CA5-D264A61999E8Q34594761-6C97594E-A292-476E-9BAA-8ADDED703ACAQ34615489-1E6A3B89-7443-453F-B973-DFE5C839FC00Q35065888-E52650CC-AA99-4C45-87F0-1A1D1F2587AEQ35261530-7F17B98C-F164-43BD-ADE1-B33A1F4318F6Q35650184-61F4FB91-BABA-498C-890D-DA1558874FC6Q36095164-002A7483-AAA3-49CF-951B-71E6B7BAB79CQ36121533-54554B98-3713-43A0-9098-16537605CA7BQ36154756-DCA4C988-247B-4187-8747-F2BC8069246CQ36170218-DDDADEB5-CA9F-4DBB-AC24-4DEA0459FB05Q36177685-EF6EC177-9737-44BE-90F0-9B966818D8A6Q36291030-7D827689-D408-440C-B267-D08AB009E1D0Q36300016-237574B9-49AB-46FF-97BE-DFCF59320476Q36362821-719E20C4-5173-4B40-BBE8-34DCD7B26876Q36458624-09AE5426-41A7-41B2-8C71-83EA91EAA924Q36518544-B8AC6FCB-E50E-4CE3-B7C6-E31651B3CEC8Q36535848-BEF6DDEA-3BE5-4DC9-B743-00183672F396Q36589458-C44992AD-4C27-4B08-BFFD-E83ED358F40DQ36898125-6DEA3F5D-338E-4D6F-B851-FF5F436B5085Q36960080-411CA6D0-79E9-4FE7-808A-C13216E1BC23Q37229923-341E5314-171F-4C3D-BF1B-14D872964F6CQ37249885-58B83DF6-5655-4E17-AF52-8D57D5AE0B50Q37318967-991FE642-46F9-4594-82C6-922EA177E8A2Q37702470-5577A324-715B-4415-84F2-13392FD9C64EQ38264045-E0C47446-EBC8-4C85-A2C3-97150765B59FQ38611455-95DBA17D-7B7F-4DBD-8C84-D0A95F5C5B40Q38746829-25AFF985-1454-4249-9CC7-4B8581CC9C8DQ38928482-287BE4D0-8790-4D3E-8CC7-2024F99C3863Q39032273-35E214E5-06E4-443C-B3AC-9DD3A85052BA
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The epidemiology of varicella and its complications.
@en
type
label
The epidemiology of varicella and its complications.
@en
prefLabel
The epidemiology of varicella and its complications.
@en
P2093
P356
P1476
The epidemiology of varicella and its complications.
@en
P2093
P304
P356
10.1093/INFDIS/172.3.706
P407
P577
1995-09-01T00:00:00Z